Jundishapur Journal of Microbiology

Published by: Kowsar

Antifungal Susceptibility Profiles of Candida Species Isolated from Ahvaz Jundishapur Educational Hospitals

Simin Taghipour 1 , 2 , Ali Rezaei-Matehkolaei 1 , 2 and Ali Zarei Mahmoudabadi 1 , 2 , *
Authors Information
1 Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jundishapur Journal of Microbiology: November 2018, 11 (11); e78851
  • Published Online: November 6, 2018
  • Article Type: Research Article
  • Received: May 14, 2018
  • Revised: October 16, 2018
  • Accepted: October 17, 2018
  • DOI: 10.5812/jjm.78851

To Cite: Taghipour S, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A. Antifungal Susceptibility Profiles of Candida Species Isolated from Ahvaz Jundishapur Educational Hospitals, Jundishapur J Microbiol. 2018 ; 11(11):e78851. doi: 10.5812/jjm.78851.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Zarei-Mahmoudabadi A, Zarrin M, Ghanatir F, Vazirianzadeh B. Candiduria in hospitalized patients in teaching hospitals of Ahvaz. Iran J Microbiol. 2012;4(4):198-203. [PubMed: 23205252]. [PubMed Central: PMC3507310].
  • 2. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33(2):177-86. doi: 10.1086/321811. [PubMed: 11418877].
  • 3. Lundstrom T, Sobel J. Nosocomial candiduria: A review. Clin Infect Dis. 2001;32(11):1602-7. doi: 10.1086/320531. [PubMed: 11340532].
  • 4. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005;147(2):166-71. doi: 10.1016/j.jpeds.2005.04.016. [PubMed: 16126043].
  • 5. Storti LR, Pasquale G, Scomparim R, Galastri AL, Alterthum F, Gambale W, et al. Candida spp. isolated from inpatients, the environment, and health practitioners in the Pediatric Unit at the Universitary Hospital of the Jundiai Medical College, State of Sao Paulo, Brazil. Rev Soc Bras Med Trop. 2012;45(2):225-31. doi: 10.1590/S0037-86822012000200017. [PubMed: 22534997].
  • 6. Fanello S, Bouchara JP, Sauteron M, Delbos V, Parot E, Marot-Leblond A, et al. Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. J Med Microbiol. 2006;55(Pt 2):223-8. doi: 10.1099/jmm.0.46155-0. [PubMed: 16434716].
  • 7. Yildirim M, Sahin I, Kucukbayrak A, Ozdemir D, Tevfik Yavuz M, Oksuz S, et al. Hand carriage of Candida species and risk factors in hospital personnel. Mycoses. 2007;50(3):189-92. doi: 10.1111/j.1439-0507.2006.01348.x. [PubMed: 17472614].
  • 8. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17(2):255-67. doi: 10.1128/CMR.17.2.255-267.2004. [PubMed: 15084500]. [PubMed Central: PMC387407].
  • 9. Mean M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care. 2008;12(1):204. doi: 10.1186/cc6212. [PubMed: 18279532]. [PubMed Central: PMC2374590].
  • 10. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49(9):3640-5. doi: 10.1128/AAC.49.9.3640-3645.2005. [PubMed: 16127033]. [PubMed Central: PMC1195428].
  • 11. Slavin M, Fastenau J, Sukarom I, Mavros P, Crowley S, Gerth WC. Burden of hospitalization of patients with Candida and Aspergillus infections in Australia. Int J Infect Dis. 2004;8(2):111-20. doi: 10.1016/j.ijid.2003.05.001. [PubMed: 14732329].
  • 12. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62(Pt 1):10-24. doi: 10.1099/jmm.0.045054-0. [PubMed: 23180477].
  • 13. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Epidemiology of Candida colonization in an intensive care unit of a teaching hospital in Kuwait. Med Mycol. 2003;41(6):487-93. doi: 10.1080/1369378031000147458. [PubMed: 14725322].
  • 14. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3(11):685-702. doi: 10.1016/S1473-3099(03)00801-6. [PubMed: 14592598].
  • 15. Davis SL, Vazquez JA, McKinnon PS. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother. 2007;41(4):568-73. doi: 10.1345/aph.1H516. [PubMed: 17374623].
  • 16. Kathiravan MK, Salake AB, Chothe AS, Dudhe PB, Watode RP, Mukta MS, et al. The biology and chemistry of antifungal agents: A review. Bioorg Med Chem. 2012;20(19):5678-98. doi: 10.1016/j.bmc.2012.04.045. [PubMed: 22902032].
  • 17. Mahmoudi S, Roustaei M, Zaini F, Kordbacheh P, Safara M. In vitro antifungal activities of Euphorbia macroclada and fluconazole against pathogenic Candida species. Curr Med Mycol. 2015;1(2):7-12. doi: 10.18869/acadpub.cmm.1.2.7. [PubMed: 28680982]. [PubMed Central: PMC5490307].
  • 18. Caston-Osorio JJ, Rivero A, Torre-Cisneros J. Epidemiology of invasive fungal infection. Int J Antimicrob Agents. 2008;32 Suppl 2:S103-9. doi: 10.1016/S0924-8579(08)70009-8. [PubMed: 19013332].
  • 19. Mohammadi R, Mirhendi H, Rezaei-Matehkolaei A, Ghahri M, Shidfar MR, Jalalizand N, et al. Molecular identification and distribution profile of Candida species isolated from Iranian patients. Med Mycol. 2013;51(6):657-63. doi: 10.3109/13693786.2013.770603. [PubMed: 23470036].
  • 20. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: A guide to methods and applications. 18. 1990. p. 315-22.
  • 21. Clinical and Laboratory Standards Institute. Refrence method for broth dilution abtifungal suceptibility testing of yeasts; approved standard-third edition. M27-A3. 28. Clinical and Laboratory Standards Institute; 2008.
  • 22. Gharaghani M, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Keikhaei B. The frequency, antifungal susceptibility and enzymatic profiles of Candida species isolated from neutropenic patients. Jundishapur J Microbiol. 2016;9(11). e41446. doi: 10.5812/jjm.41446. [PubMed: 28138378]. [PubMed Central: PMC5240162].
  • 23. Fothergill AW. Miconazole: A historical perspective. Expert Rev Anti Infect Ther. 2006;4(2):171-5. doi: 10.1586/14787210.4.2.171. [PubMed: 16597199].
  • 24. Rathod VS, Raut JS, Mohan Karuppayil S. Antifungal drug susceptibility of Candida albicans isolates from pulmonary tuberculosis patients. Int J Pharm Pharm Sci. 2012;4(Suppl 5):323-6.
  • 25. Rezaei-Matehkolaei A, Shafiei S, Zarei-Mahmoudabadi A. Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species. Iran J Microbiol. 2016;8(6):410-7. [PubMed: 28491253]. [PubMed Central: PMC5420397].
  • 26. Amran F, Aziz MN, Ibrahim HM, Atiqah NH, Parameswari S, Hafiza MR, et al. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia. J Med Microbiol. 2011;60(Pt 9):1312-6. doi: 10.1099/jmm.0.027631-0. [PubMed: 21459913].
  • 27. Pfaller MA. Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment. Am J Med. 2012;125(1 Suppl):S3-13. doi: 10.1016/j.amjmed.2011.11.001. [PubMed: 22196207].
  • 28. Shin JH, Kim MN, Jang SJ, Ju MY, Kim SH, Shin MG, et al. Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods. J Clin Microbiol. 2012;50(6):1852-5. doi: 10.1128/JCM.06440-11. [PubMed: 22442324]. [PubMed Central: PMC3372122].
  • 29. St-Germain G, Laverdiere M, Pelletier R, Rene P, Bourgault AM, Lemieux C, et al. Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: Report on 453 cases between 2003 and 2005. Can J Infect Dis Med Microbiol. 2008;19(1):55-62. doi: 10.1155/2008/634046. [PubMed: 19145263]. [PubMed Central: PMC2610277].
  • 30. Negri M, Martins M, Henriques M, Svidzinski TI, Azeredo J, Oliveira R. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia. 2010;169(3):175-82. doi: 10.1007/s11046-009-9246-0. [PubMed: 19851885].
  • 31. Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Muhlethaler K, et al. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: A 6-year prospective candidaemia survey from the fungal infection network of Switzerland. Clin Microbiol Infect. 2014;20(7):698-705. doi: 10.1111/1469-0691.12440. [PubMed: 24188136].
  • 32. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol. 2012;50(4):1199-203. doi: 10.1128/jcm.06112-11.
  • 33. Santos ER, Dal Forno CF, Hernandez MG, Kubica TF, Venturini TP, Chassot F, et al. Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints. Rev Inst Med Trop Sao Paulo. 2014;56(6):477-82. doi: 10.1590/S0036-46652014000600004. [PubMed: 25351540]. [PubMed Central: PMC4296866].
  • 34. Baghdadi E, Khodavaisy S, Rezaie S, Abolghasem S, Kiasat N, Salehi Z, et al. Antifungal susceptibility patterns of Candida species recovered from endotracheal tube in an intensive care unit. Adv Med. 2016;2016:9242031. doi: 10.1155/2016/9242031. [PubMed: 27642628]. [PubMed Central: PMC5011531].
  • 35. Savastano C, de Oliveira Silva E, Goncalves LL, Nery JM, Silva NC, Dias AL. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital. Braz J Microbiol. 2016;47(2):367-72. doi: 10.1016/j.bjm.2015.05.001. [PubMed: 26991302]. [PubMed Central: PMC4874588].
  • 36. Bonassoli LA, Svidzinski TI. Influence of the hospital environment on yeast colonization in nursing students. Med Mycol. 2002;40(3):311-3. doi: 10.1080/mmy.40.3.311.313. [PubMed: 12146762].
  • 37. Bonassoli LA, Bertoli M, Svidzinski TI. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect. 2005;59(2):159-62. doi: 10.1016/j.jhin.2004.06.033. [PubMed: 15620452].
  • 38. Mosayebi M, Eslamirad Z, Hajihossein R, Ghorbanzadeh B, Shahverdi M, Didehdar M. Evaluating of fungal contamination in hospital wet cooling systems in Markazi province, Central Iran. J Mycol Med. 2017;27(3):334-8. doi: 10.1016/j.mycmed.2017.04.003. [PubMed: 28754461].
  • 39. Sabino R, Sampaio P, Carneiro C, Rosado L, Pais C. Isolates from hospital environments are the most virulent of the Candida parapsilosis complex. BMC Microbiol. 2011;11:180. doi: 10.1186/1471-2180-11-180. [PubMed: 21824396]. [PubMed Central: PMC3166928].
  • 40. Wadile RG, Bhate VM. Study of clinical spectrum and risk factors of neonatal candidemia. Indian J Pathol Microbiol. 2015;58(4):472-4. doi: 10.4103/0377-4929.168888. [PubMed: 26549069].
  • 41. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288-305. doi: 10.1111/j.1574-6976.2011.00278.x. [PubMed: 21569057].
  • 42. Isham N, Ghannoum MA. Antifungal activity of miconazole against recent Candida strains. Mycoses. 2010;53(5):434-7. doi: 10.1111/j.1439-0507.2009.01728.x. [PubMed: 19531099].
  • 43. Badiee P, Alborzi A. Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study. Iran J Microbiol. 2011;3(4):183-8. [PubMed: 22530086]. [PubMed Central: PMC3330181].
  • 44. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: Analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol. 2008;46(8):2620-9. doi: 10.1128/JCM.00566-08. [PubMed: 18579718]. [PubMed Central: PMC2519503].
  • 45. Amanloo S, Shams-Ghahfarokhi M, Ghahri M, Razzaghi-Abyaneh M. Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin. Rev Iberoam Micol. 2018;35(2):88-91. doi: 10.1016/j.riam.2018.01.002. [PubMed: 29685375].
  • 46. Shokohi T, Badali H, Amirrajab N, Ataollahi MR, Kouhpayeh SA, Afsarian MH. In vitro activity of five antifungal agents against Candida albicans isolates, Sari, Iran. Curr Med Mycol. 2016;2(2):34-9. doi: 10.18869/acadpub.cmm.2.2.8. [PubMed: 28681018]. [PubMed Central: PMC5490303].
  • 47. Bonfietti LX, Szeszs MW, Chang MR, Martins MA, Pukinskas SR, Nunes MO, et al. Ten-year study of species distribution and antifungal susceptibilities of Candida bloodstream isolates at a Brazilian tertiary hospital. Mycopathologia. 2012;174(5-6):389-96. doi: 10.1007/s11046-012-9566-3. [PubMed: 22821345].
  • 48. Kooshki P, Rezaei-Matehkolaei A, Mahmoudabadi AZ. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran. J Mycol Med. 2018;28(2):340-4. doi: 10.1016/j.mycmed.2018.02.010. [PubMed: 29530715].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments